SCHEMBL13861883

SCHEMBL13861883

CC(C)[C@@H](CO)n1cc(C(=O)O)c(=O)c2cc(Cc3cccc(Cl)c3F)c(Oc3cccnc3)cc21

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METTL3 Q86U44 1/20 0.76
▸ SGMS2 Q8NHU3 1/20 0.35
▸ PDCD1 Q15116 3/20 0.33
▸ CD274 Q9NZQ7 3/20 0.33
▸ P2RX4 Q99571 1/20 0.32
▸ NTRK1 P04629 2/20 0.32
▸ TOP2A P11388 1/20 0.32
▸ TOP2B Q02880 1/20 0.32
▸ PIK3CG P48736 1/20 0.31
▸ PRKAB2 O43741 1/20 0.31
▸ PRKAG1 P54619 1/20 0.31
▸ PRKAA2 P54646 1/20 0.31
▸ PRKAA1 Q13131 1/20 0.31
▸ PRKAG3 Q9UGI9 1/20 0.31
▸ PRKAG2 Q9UGJ0 1/20 0.31
▸ PRKAB1 Q9Y478 1/20 0.31
▸ SCN9A Q15858 2/20 0.31
▸ GPR132 Q9UNW8 1/20 0.30
▸ ATR Q13535 1/20 0.30
▸ PLA2G4A P47712 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4364224 0.99 METTL3 (0.75) METTL3SGMS2PDCD1CD274P2RX4
SCHEMBL4365485 0.92 METTL3 (0.84) METTL3PLA2G4A
SCHEMBL4374954 0.89 METTL3 (0.75) METTL3SGMS2PDCD1CD274PRKAB2
Elvitegravir SCHEMBL13225651 0.86 METTL3 (1.00) METTL3PLA2G4A
Elvitegravir SCHEMBL726251 0.86 METTL3 (1.00) METTL3PLA2G4A
Elvitegravir SCHEMBL726252 0.86 METTL3 (1.00) METTL3PLA2G4A
Elvitegravir SCHEMBL29623981 0.86 METTL3 (1.00) METTL3PLA2G4A
SCHEMBL1045112 0.86 METTL3 (0.86) METTL3PLA2G4A
SCHEMBL3245266 0.86 METTL3 (0.86) METTL3PLA2G4A
Elvitegravir SCHEMBL1050765 0.86 METTL3 (0.98) METTL3PLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7531554-B2 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid JAPAN TOBACCO INC. (JP) 2009-05-12 — — US disclosed
US-7531554-B2 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid JAPAN TOBACCO INC. (JP) 2009-05-12 — — US disclosed
Send feedback